ScreenerHero vs TradingView
TradingView has the best
charts in the world.
ScreenerHero has better
European fundamentals.
TradingView is the most technically capable platform for chart-driven investing. For European fundamental screening — especially below large cap — the data quality has real gaps. ScreenerHero is built specifically for the case TradingView handles poorly: systematic fundamental screening of European equities including microcaps on alternative markets.
Updated May 2026 · Honest comparison, including where TradingView is genuinely better
The core difference
TradingView is a charting platform with a screener attached
The screener is a feature within a chart-first product. The data infrastructure is optimised for price data and technical indicators. Fundamental data for European small caps — especially alternative market listings on Euronext Growth, First North, and EGM — is inconsistent and often missing below ~€500M market cap.
ScreenerHero is a screener with charts attached
The screener is the product. Every data decision — which exchanges to cover, which fundamental fields to prioritise, how to handle missing data — is made with European fundamental screening as the primary use case. Charts are functional and useful, but they are not the reason to use ScreenerHero.
Where TradingView is genuinely better
Where ScreenerHero is genuinely better
Side-by-side comparison
| ScreenerHero | TradingView | |
|---|---|---|
| European stock coverage | Full — all active instruments including microcaps | Global including Europe — but microcap data gaps |
| European microcap fundamentals | P/E, ROE, EV/EBITDA, margins — reliable for EU small caps | Inconsistent below €500M — data often missing for alternative markets |
| Charting quality | Basic price charts — functional, not the focus | World-class — best charting platform available |
| Screener filter depth | P/E, P/B, ROE, EV/EBITDA, margins, beta, dividend — all reliable for EU | Many filters — reliability for small European exchanges limited on free plan |
| Free tier | Full screener free — no account required | Screener restricted on free plan — filters limited, alerts require paid plan |
| Price (paid plans) | €24/mo Pro · annual discounts available | $15–60/mo Essential to Ultimate |
| Heatmap | European market heatmap included | Global heatmap — excellent, especially for US |
| UI density | Desktop-first, data-dense — built for fundamental screening | Chart-first — screener is secondary to the charting workflow |
| Alternative markets (First North, Euronext Growth, EGM) | Covered — including Euronext Growth, First North, EGM, NewConnect | Partial — main market listings more reliable than alternative markets |
| No signup required | Yes — full screener accessible without account | No — account required for screener access |
✓ = strong advantage · − = partial or qualified · ✗ = absent or weak
Which to use — by workflow
Can you use both?
Yes — and many European investors do. A common workflow: use ScreenerHero to identify companies that pass fundamental criteria across European exchanges, then open TradingView to review the price history, chart the technical setup, and set alerts for price levels of interest. The two tools complement each other better than either replaces the other. ScreenerHero is free to start — no account needed.
Try the European fundamental screener TradingView doesn't have.
P/E, ROE, EV/EBITDA, margins, dividend yield across 14 European exchanges — including microcaps on Euronext Growth, First North, EGM, and NewConnect. Free, no account needed.